Zimmer Biomet Holdings Inc

ZBH | Healthcare | NYSE
$93.10
+2.14 (+2.35%)

Key Metrics

Market Cap
$18.01B
P/E Ratio
10.98
EPS
$8.48
Beta
N/A
Dividend Yield
N/A
ROE
6.01%
Current Ratio
1.73

Company Information

Industry
Medical Devices

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc engages in the design manufacture and marketing of orthopedic reconstructive products The firm also offers sports medicine biologics extremities and trauma products spine craniomaxillofacial and thoracic products officebased technologies dental implants and related surgical products It operates through the following geographical segments Americas Europe Middle East and Africa and Asia Pacific The Americas segment consists of the US and includes other North Central and South American markets The Europe Middle East and Africa segment includes France Germany Italy Spain and the United Kingdom The Asia Pacific segment refers to the key markets such as Japan China Australia New Zealand Korea Taiwan India Thailand Singapore Hong Kong and Malaysia The company was founded by Justin O Zimmer in 1927 and is headquartered in Warsaw IN

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-04-28 $2.09 $1.86 +12.4%
2026-02-10 $2.42 $2.38 +1.7%
2025-11-05 $1.90 $1.87 +1.6%
2025-08-07 $2.07 $1.98 +4.5%

Financial Ratios (TTM)

Gross Margin
70.03%
Operating Margin
15.61%
Net Margin
9.05%
ROA
3.35%
Price to Book
1.43
Price to Sales
2.14